These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 10886608)
1. Susceptibility of multiresistant strains of Burkholderia cepacia to honey. Cooper RA; Wigley P; Burton NF Lett Appl Microbiol; 2000 Jul; 31(1):20-4. PubMed ID: 10886608 [TBL] [Abstract][Full Text] [Related]
2. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients]. Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760 [TBL] [Abstract][Full Text] [Related]
3. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. Shelly DB; Spilker T; Gracely EJ; Coenye T; Vandamme P; LiPuma JJ J Clin Microbiol; 2000 Aug; 38(8):3112-5. PubMed ID: 10921992 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Vu-Thien H; Moissenet D; Valcin M; Dulot C; Tournier G; Garbarg-Chenon A Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):876-9. PubMed ID: 8997562 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary function, serum markers of inflammation, and IgG antibodies to core lipopolysaccharide of Burkholderia cepacia in adults with cystic fibrosis, following colonization with Burkholderia cepacia. Hendry J; Nixon L; Dodd M; Elborn JS; Govan J; Shale DJ; Webb AK Pediatr Pulmonol; 2000 Jan; 29(1):8-10. PubMed ID: 10613780 [TBL] [Abstract][Full Text] [Related]
6. A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey. Jenkins R; Wootton M; Howe R; Cooper R Arch Microbiol; 2015 May; 197(4):597-601. PubMed ID: 25680398 [TBL] [Abstract][Full Text] [Related]
7. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887 [TBL] [Abstract][Full Text] [Related]
8. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Dales L; Ferris W; Vandemheen K; Aaron SD Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248 [TBL] [Abstract][Full Text] [Related]
9. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828 [TBL] [Abstract][Full Text] [Related]
10. [The epidemiology of Burkholderia cepacia in cystic fibrosis patients: the initial results of a study including the genotypic typing of the strains isolated]. Villari P; Iacuzio L; Vozzella EA; Raia V; Torre I Ann Ig; 1999; 11(6):501-6. PubMed ID: 10596443 [No Abstract] [Full Text] [Related]
11. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517 [TBL] [Abstract][Full Text] [Related]
12. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa. Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094 [TBL] [Abstract][Full Text] [Related]
13. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. Whitby PW; Dick HL; Campbell PW; Tullis DE; Matlow A; Stull TL J Clin Microbiol; 1998 Jun; 36(6):1642-5. PubMed ID: 9620393 [TBL] [Abstract][Full Text] [Related]
14. Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients. Hyde J; Humphreys H Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):253-4. PubMed ID: 9131333 [No Abstract] [Full Text] [Related]
15. Isolation of Burkholderia cepacia by enrichment. Flanagan PG; Paull A J Clin Pathol; 1998 Jul; 51(7):557-8. PubMed ID: 9797739 [TBL] [Abstract][Full Text] [Related]
16. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia. Ledson MJ; Gallagher MJ; Robinson M; Cowperthwaite C; Williets T; Hart CA; Walshaw MJ J Aerosol Med; 2002; 15(1):51-7. PubMed ID: 12006145 [TBL] [Abstract][Full Text] [Related]
17. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098 [TBL] [Abstract][Full Text] [Related]
19. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Häussler S; Lehmann C; Breselge C; Rohde M; Classen M; Tümmler B; Vandamme P; Steinmetz I Eur J Clin Microbiol Infect Dis; 2003 Apr; 22(4):249-53. PubMed ID: 12687415 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance in Burkholderia cepacia at two regional cystic fibrosis centres in Northern Ireland: is there a need for synergy testing? Moore JE; Crowe M; Shaw A; McCaughan J; Redmond AO; Elborn JS J Antimicrob Chemother; 2001 Aug; 48(2):319-21. PubMed ID: 11481312 [No Abstract] [Full Text] [Related] [Next] [New Search]